Alzheimer’s disease (AD) is the most common form of dementia, affecting more than five million people in the US alone; it’s also the sixth leading cause of deaths in the country.
Here’s a closer look at those Alzheimer’s disease treatment stocks.
Actinogen Medical (ASX:ACW)Market cap: AUD$38.11 million; current share price: AUD$0.05First on our Alzheimer’s disease treatment stocks list is Actinogen Medical.
Axsome Therapeutics (NASDAQ:AXSM)Market cap: $170.18 million; current share price: $1.58Middle of the pack on our Alzheimer’s disease treatment stocks list is Axsome Therapeutics.
5. vTv Therapeutics (NASDAQ:VTVT)Market cap: $191.62 million; current share price: $5.84Closing out our Alzheimer’s disease treatment stocks list is vTv Therapeutics.